Skip to main content
Top
Published in: Rheumatology International 8/2005

01-10-2005 | Original Article

Antiphospholipid syndrome and palindromic rheumatism: a new possible association

Authors: Tatiana Reitblat, Irena Litinsky, Dan Caspi, Ori Elkayam

Published in: Rheumatology International | Issue 8/2005

Login to get access

Abstract

Objective

The aim of this study was to report six patients with palindromic rheumatism (PR) in whom signs, symptoms, and/or serologic evidence of antiphospholipid syndrome (APS) developed.

Methods

The medical histories of the patients were reviewed with special emphasis on age, gender, duration of PR, and lapse of time until antiphospholipid antibodies were detected or APS was diagnosed. Three representative cases are described.

Results

Two patients were women and four were men. Their mean age was 49.3 years (range 36–80), and the mean duration of PR was 5.5 years (range 3–8). In all patients, raised titers of antiphospholipid antibodies were found on two or more occasions. Two patients developed clinical pictures compatible with APS, two showed symptoms which may be attributable for APS, and raised titers of antiphospholipid antibodies were found in only two.

Conclusion

It seems that the appearance of these two uncommon conditions together is more than coincidental and may point to a previously unreported clinical association.
Literature
1.
go back to reference Hench PS, Rosenberg EF (1944) Palindromic rheumatism. A “new” off recurring disease of joints (arthritis, periarthritis, para-arthritis) apparently producing no articular residues. Report of thirty-four cases; its relation to “angio-neural arthritis”, “allergic rheumatism” and rheumatoid arthritis. Arch Intern Med 73:293–321 Hench PS, Rosenberg EF (1944) Palindromic rheumatism. A “new” off recurring disease of joints (arthritis, periarthritis, para-arthritis) apparently producing no articular residues. Report of thirty-four cases; its relation to “angio-neural arthritis”, “allergic rheumatism” and rheumatoid arthritis. Arch Intern Med 73:293–321
2.
go back to reference Guerne P-A, Weisman MH (1992) Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med 93:451–460CrossRefPubMed Guerne P-A, Weisman MH (1992) Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med 93:451–460CrossRefPubMed
3.
go back to reference Hannonen P, Mottorien T, Oka M (1987) Palindromic rheumatism. A clinical survey of sixty patients. Scand J Rheumatol 16:413–420PubMed Hannonen P, Mottorien T, Oka M (1987) Palindromic rheumatism. A clinical survey of sixty patients. Scand J Rheumatol 16:413–420PubMed
4.
go back to reference Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez-Almazor ME (1999) Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol 26:540–545PubMed Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez-Almazor ME (1999) Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol 26:540–545PubMed
5.
go back to reference Pastaro G, Barbieri P (1986) Palindromic rheumatism: you just have to think about it. Clin Exp Rheumatol 4:197–199PubMed Pastaro G, Barbieri P (1986) Palindromic rheumatism: you just have to think about it. Clin Exp Rheumatol 4:197–199PubMed
6.
go back to reference Hughes GRV, Harris EN, Gharavi AE (1987) The anticardiolipin syndrome. J Rheumatol 13:486–489 Hughes GRV, Harris EN, Gharavi AE (1987) The anticardiolipin syndrome. J Rheumatol 13:486–489
7.
go back to reference Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311CrossRefPubMed Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311CrossRefPubMed
8.
go back to reference Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211–1214CrossRefPubMed Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211–1214CrossRefPubMed
9.
go back to reference Asherson RA (1988) A “primary” antiphospholipid syndrome? J Rheumatol 15:1742–1746PubMed Asherson RA (1988) A “primary” antiphospholipid syndrome? J Rheumatol 15:1742–1746PubMed
10.
go back to reference Merkel PA, Chang YC, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 106:576–583CrossRef Merkel PA, Chang YC, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 106:576–583CrossRef
11.
go back to reference Cervera R, Garcia-Carrasco M, Font J, Ramos C, Espinosa G, Ingelmo M (1997) Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in series of 80 patients. Clin Exp Rheumatol 15:361–365PubMed Cervera R, Garcia-Carrasco M, Font J, Ramos C, Espinosa G, Ingelmo M (1997) Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in series of 80 patients. Clin Exp Rheumatol 15:361–365PubMed
12.
go back to reference Juanola X, Mateo L, Domenech P, Bas J, Contreras N, Nolla JM, Roig-Escofet D (1995) Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis. J Rheumatol 22:1891–1993PubMed Juanola X, Mateo L, Domenech P, Bas J, Contreras N, Nolla JM, Roig-Escofet D (1995) Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis. J Rheumatol 22:1891–1993PubMed
13.
go back to reference Youssef W, Yan A, Russell AS (1991) Palindromic rheumatism: a response to chloroquine. J Rheum 18:35–37PubMed Youssef W, Yan A, Russell AS (1991) Palindromic rheumatism: a response to chloroquine. J Rheum 18:35–37PubMed
14.
go back to reference Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO (1987) Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 123:590–600CrossRefPubMed Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO (1987) Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 123:590–600CrossRefPubMed
15.
go back to reference Neklyudov L, Gradzka M, Conti-Kelli AM, Greco TP (2000) Erythema nodosum associated with antiphospholipid antibodies: a report of three cases. Lupus 9:641–645CrossRefPubMed Neklyudov L, Gradzka M, Conti-Kelli AM, Greco TP (2000) Erythema nodosum associated with antiphospholipid antibodies: a report of three cases. Lupus 9:641–645CrossRefPubMed
16.
go back to reference Elkayam O, Yaron M, Brazowski E, Caspi D (1998) Rheumatoid nodules in a patient with primary antiphospholipid (Hughes) syndrome. Lupus 7:488–491CrossRefPubMed Elkayam O, Yaron M, Brazowski E, Caspi D (1998) Rheumatoid nodules in a patient with primary antiphospholipid (Hughes) syndrome. Lupus 7:488–491CrossRefPubMed
17.
go back to reference Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerro J, Alarcon-Segovia D (1990) Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 17:34–37PubMed Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerro J, Alarcon-Segovia D (1990) Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 17:34–37PubMed
18.
go back to reference Inzelberg R, Korczyn AD (1989) Lupus anticoagulant and late onset seizures. Acta Neurol Scand 79:114–118PubMed Inzelberg R, Korczyn AD (1989) Lupus anticoagulant and late onset seizures. Acta Neurol Scand 79:114–118PubMed
19.
go back to reference Cervera R, Asherson RA, Font J, Tikly M, Pallares L, Chamorro A, Ingelmo M (1997) Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 76:203–212 Cervera R, Asherson RA, Font J, Tikly M, Pallares L, Chamorro A, Ingelmo M (1997) Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 76:203–212
20.
go back to reference Garcia-Torres R, Amigo MC, De la Rosa A, Moron A, Reyes PA (1996) Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 5:56–61PubMed Garcia-Torres R, Amigo MC, De la Rosa A, Moron A, Reyes PA (1996) Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 5:56–61PubMed
Metadata
Title
Antiphospholipid syndrome and palindromic rheumatism: a new possible association
Authors
Tatiana Reitblat
Irena Litinsky
Dan Caspi
Ori Elkayam
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0489-2

Other articles of this Issue 8/2005

Rheumatology International 8/2005 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.